Pharma field force · samples, promotional items, congress kits · AMD invoicing

Medical Representatives Field Merchandise

A medical representative carries three different categories of object, and the law and the internal policy treat each of them differently: regulated samples, non-prescription promotional items, and branded gifts that most companies restrict sharply or prohibit altogether. This page is written for the people who buy what the field force carries and for the marketing and medical affairs teams who have to defend it — commercial operations managers, field force managers, marketing managers, medical affairs and the distribution lead in Armenia. It covers what a representative actually needs on a territory round, why the three categories must never be printed on the same object, how cold-chain and leaflet obligations change the specification, and how distributor-supplied items get rebranded when nobody intended it.

Send a field-force brief Other audiences

What a territory round actually requires

The field force is a logistics operation before it is a selling operation. A representative carries a bag, and everything about that bag is decided by someone else — usually marketing, sometimes medical affairs, occasionally the distributor — and rarely by the person who has to open it twelve times a day between clinics. The specification follows from the working day rather than from the brand: how many calls are in the route, how long a typical call runs, whether the representative parks at the clinic or moves between several buildings, whether the vehicle carries a load, and what has to survive being put down on a car seat in July. A bag designed for a trade exhibition fails in the field, and a bag designed for the field looks wrong at a congress. Both exist, and the usual outcome is that the company buys the exhibition bag for a field force that uses it every day, then replaces it within a year.

The second consideration is the representative's own visibility. In most regulated markets a representative must be able to identify themselves and the purpose of the contact on request, and must be able to produce identification when asked. That obligation is easy to meet and easy to overlook, because it is usually met by an identity card issued by the company or the distributor rather than by merchandise. Where the marketing budget does cover the identity card, the card holder becomes a print item, which brings with it a replacement cycle every time somebody joins or leaves, a bilingual requirement in practice, and a design that has to survive being carried in a wallet for three years. In Armenia, Armenian is the working language of clinical contact; Russian and English appear in printed material and in hospital administration often enough that a trilingual print is the practical choice for anything a representative hands over rather than wears.

The third is sample handling, which is where the merchandise decision stops being a marketing decision. Samples are regulated goods: they move under pharmaceutical distribution rules, they are traceable, they carry expiry dates, and they are counted. How many a representative may hold at one time, whether a request must be documented by the prescriber, what happens to expired stock, and whether a sample may be left behind — these are questions of national rules and of company policy, and they are not merchandise questions. What merchandise can do is make the correct behaviour easier. A carrier with a dedicated sealed compartment and a printed count sheet is doing compliance work. A shoulder bag with an open side pocket that a rep will top up from at the end of the day is not, whatever the brochure says.

The fourth is the calendar, and in pharmaceuticals it is unusual. Three fixed points shape the year more than any other purchasing decision in B2B: the annual tender cycle for centrally procured medicines, the congress season, and the internal budget year. Tenders set the volume and the territory structure, congresses set the visibility, and the budget year sets when an order can actually be placed. Between those points sits the ordinary restock, and the restock is where most field forces actually get their replacement bags from — which means the replacement has to carry the same artwork as the original, or the territory ends up with mixed branding in front of the same customer for two years.

Field force size: 60-400 representatives per company or distributor in Armenia
Order profile: 200-1,500 pieces per run, sized to territory count
Restock cycle: 18-30 months for bags; 12 months for printed collateral
Indicative spend: 9,000-38,000 AMD per representative kit
Billing currency: AMD, invoiced in AMD with VAT stated separately
Lead time: 18-30 working days; 10-14 days for unprinted replacement stock

Four programmes that field forces actually consume

Pharmaceutical merchandising divides cleanly into four programmes, and they sit in different budgets, on different lead times, and under different review regimes. Mixing them — most often by producing one item that tries to serve two of them — is the most common avoidable error in this category.

Sample carriers and cold-chain handling

A sample carrier is a piece of equipment, not a giveaway, and it should be specified like one. The decision that matters is whether it holds product at all: an insulated compartment with a conditioned gel pack maintains a nominal two-to-eight degree Celsius range for a working day, which is what a good distribution practice regime requires for the transport of temperature-sensitive product, and it must be conditioned before loading rather than frozen, because a frozen pack that touches product does damage that no amount of later handling repairs. Insulated carriers are built with a rigid outer shell, a sealed lid, a printable panel and a printed count sheet, and they are conditioned, loaded and sealed in a documented sequence. Two practical points that specifications usually miss. The count sheet belongs in the lid, printed rather than handwritten, because a handwritten sheet is the record that fails an audit. And the carrier has to be cleaned and returned for a periodic integrity check, because an insulated shell degrades and a degraded shell fails silently in August. Where a company ships samples through a third-party logistics provider, the carrier's specification is often already fixed by the provider, and the printable area on it is small; that constraint should be established before the design, not after it.

Identity, territory and representative kits

This is the apparel and accessory programme, and it is where a distributor's control problem usually appears. A representative working a territory is a mobile advertisement, and the standard artefact is a light outer layer plus a bag: a jacket, a gilet or a soft-shell, a shoulder bag with an internal document compartment, and a card holder for the identity card that has to be produced on request. Apparel sizing in a field force is unusually specific, because reps are spread across a country rather than concentrated at a head office, and the size distribution is not the national one — a size chart averaged across a national workforce produces a run that fits a third of the field force and leaves the rest with samples. The remedy is to collect sizes by territory and by person, reconcile them against the HR or distributor master rather than against an email thread, and reconcile again before the sample run, because a garment that arrives in the wrong size is unusable and unsaleable. Card holders and lanyard reels are the two items most often supplied by the distributor rather than by the manufacturer, and they are exactly the two items most often produced without the approval of the rights holder — a point worth raising with the commercial lead before the next tender cycle rather than after it.

Congress and continuing-education kits

Congresses are where pharmaceutical merchandise becomes visible outside the clinical relationship, and where the three-category separation is hardest to maintain. The working kit for a congress stand or a satellite session is deliberately low-key: a printed stand-level literature display, a notepad sized for an A4 insert, a pen, and a printed programme or abstract summary where the rights holder has cleared it. This is one of the few places where a notebook earns its place, because the notepad carries an abstract or a summary that a clinician may want to keep, and keeping it is the point. Items given away to attendees at a congress sit closer to the promotional line than items given to the company's own presenters, and the boundary is set by company policy rather than by the vendor, so the brief should state which side of it the programme sits on and why. Where a company runs a booth at an international congress outside Armenia, the printing specification changes substantially — larger-format panels, a different substrate, different power and rigging requirements — and it is better to run those through a local print partner with congress experience than through a garment supplier. Satellite sessions and speaker programmes generate a separate, smaller set of items for a specific named list of people, and that list is personal data with the same handling conditions described in our privacy material.

Promotional item ranges that pass review

The long-running problem in this category is the branded gift. Most pharmaceutical companies restrict them tightly, and some prohibit them outright for prescribers, because a gift to a healthcare professional is difficult to defend and easy to criticise. What survives review is usually functional rather than decorative: a notepad, a pen, a printed reference card, a bag for carrying printed material, a lanyard for a company event. What does not survive is anything that travels home and becomes a personal possession, anything of perceptible value given in a one-to-one clinical context, and anything that could be described as a inducement. Two design habits help more than any other change. First, keep the decoration flat: a single-colour print of the mark and the therapeutic area or the product family, rather than a gradient, a photograph or a large typographic treatment, because flat prints photograph cleanly and do not create the impression of a consumer brand. Second, separate the promotional item from the sample physically on the specification — different compartments, different bags, different paperwork — so that anyone auditing a delivery can see that the two never travelled together. For internal review, we can present the range as a specification sheet with unit costs and quantities, so that the marketing, medical and compliance reviewers see the same document rather than a photograph in an email.

Why samples, promotional items and branded gifts cannot share an object

Almost every question that reaches us from pharmaceutical marketing teams collapses into this one. The three categories are kept apart because each has a different regulatory status, a different audit trail and a different failure mode, and combining them creates problems that only appear during an inspection rather than during a production run.

Samples are regulated goods. A medicinal product supplied free of charge to a healthcare professional or to a patient travels under pharmaceutical distribution rules, and in most jurisdictions those rules include a cap on the quantity a representative may hold at one time, a documented request from the prescriber, full batch traceability, defined handling of expired or near-expiry stock, and a record of what was done with it. Armenia regulates the advertising of medicines and applies restrictions on how prescription products may be presented to the general public; where a company's product is also marketed in the European Union, the EU framework applies to those packs, including the Falsified Medicines Directive 2011/62/EU serialisation requirements that make a pack verifiable at dispensing. None of that is a merchandise specification, and all of it shapes one. A bag that holds both samples and promotional stock has no compartment structure that an auditor can read, and it produces a stock count that cannot be reconciled. Specify them separately: a dedicated carrier for samples, condition and seal it as a discrete step, print the count sheet as part of the carrier, and keep promotional stock out of it entirely.

Promotional items are non-prescription-marketed objects. Anything given to a healthcare professional that is not a sample and not a gift falls into the promotional category, and its acceptability is decided by company policy, usually reinforced by an industry code. The design habits that make an item acceptable are unglamorous. Use the company mark or the product family mark rather than a product-specific presentation where the brand architecture requires it. Avoid claims of any kind on the object itself, including therapeutic claims, since a printed claim on a pen is still a printed claim. Avoid items that would be at home in a kitchen, on a desk that faces a patient, or in a car. Avoid anything in white or in a colour close to a competitor's identity. And keep the value modest enough that nobody has to run an internal threshold analysis to justify it, because the threshold analysis is where slow approvals come from.

Branded gifts are the restricted category. This is where the line is drawn in most company policies and where the reputational exposure sits. The safe operating position is to design a range that a compliance reviewer can approve without a discussion, because a range that needs a discussion will eventually be approved once under time pressure. That means functional objects, printed flat, modest in value, given in an event or educational context rather than in a one-to-one clinical setting, and documented at the specification level rather than at the gifting level. We do not advise on compliance policy and we do not supply medicinal products; we produce the physical objects, and we will work to whatever specification your policy produces, including a very narrow one.

Two further constraints follow from the printed side of the category. The first is language. Anything a representative hands to a clinician has to exist in a language the clinician reads, which in practice means Armenian, frequently with Russian and English alongside it for hospital and administrative contexts, and it means the artwork has to be checked by someone who reads all three — a translation error in a leaflet-adjacent item is not a cosmetic problem. Braille and large-print versions of patient-facing material are an obligation in European markets and a good practice elsewhere; a large-print reference card is a legitimate merchandise line and is one of the few items that reaches a patient rather than a prescriber. The second is the leaflet itself. Printed matter follows its own customs treatment inside the EAEU — medicinal products in measured doses or retail packings commonly follow heading 3004, printed business matter follows 4911, note pads and registers follow 4820.10, and the storage media that congress kits increasingly include follow the current headings for solid-state storage rather than the older consolidated heading for magnetic media — and it has to be handled so that the printed stock stays clean, dry and flat. A carton of leaflets stored on a vehicle roof in Yerevan in July is not a distribution problem; it is a reprint.

A field-supply schedule that matches the pharma year

Pharmaceutical merchandising has a longer planning horizon than most B2B categories, because the quantities follow a sales organisation rather than an event, and the sales organisation is set by the territory plan. That makes the schedule longer but considerably less reactive, which is an advantage: the production window is never the problem, the approval window is.

Step 1 — Six to nine months out: territory plan and budget line

Establish the number of representatives who will be in the field at the start of the year and at the end of it, because the two numbers are rarely the same and the difference is what determines the buffer. Split that figure by territory rather than by country, because the size distribution across the field force does not follow the national distribution and a size chart averaged across a national workforce produces a run that fits a third of the representatives. Confirm which items the distributor supplies and which the manufacturer supplies, and write that down, because the item most often supplied by both parties without agreement is the representative's bag and identity card holder, and the outcome is mixed branding in the same territory. Open the compliance review at this point rather than at the artwork stage: whether the range is gifts, promotional items or both, and what the internal threshold analysis requires. A review started six months out is a paragraph; a review started three weeks before delivery is a delay.
Step 2 — Four to six months out: sample, artwork lock and approval

Physical samples are approved before artwork is finalised, because fabric weight, print coverage and panel size determine what fits. One mock-up per SKU is produced in two to three working days. Artwork is then locked with Pantone references rather than colour names, and with a technical drawing that fixes logo placement and print dimensions. For anything carrying text, the three-language check is done here, by a person who reads all three languages, and the layout accounts for the fact that Armenian text sets longer than the equivalent Russian and expands further in print at the same point size. Where a congress item carries an abstract or a summary, that text comes from medical affairs or the congress sponsor's rights holder and arrives as final copy; a layout that has to accommodate text arriving late will be the layout that goes to print with a placeholder, which is the one thing that cannot be corrected after the press run.
Step 3 — Eight to three weeks out: production, pre-shipment inspection and stock

Production runs fourteen to thirty working days depending on the decoration method; embroidery sits at the longer end because the stitch count depends on the artwork, and digital printing on non-textile items is shorter. Pre-shipment inspection is carried out on assembled goods rather than on components, and it checks the things that only appear at assembly: print registration across a seam, embroidery density on a knit, the presence of a printed count sheet inside a sample carrier lid, the correctness of personalisation against the recipient list, carton labelling by size, and whether any promotional item has ended up in a carton marked for samples. The size separation is done at packing rather than at picking, and the carton is labelled by size, because a mixed carton in a field-supply run becomes a distribution problem in the fourth week rather than a production problem in the second. Where replacement stock is being produced for later restock, it is packed and stored separately from the current dispatch so that it can be drawn against later without an artwork change.
Step 4 — Delivery, allocation and restock

Delivery to a single central point in Yerevan rather than to representatives individually, because a consolidated delivery is inspectable and a distributed one is not. The count is taken against the delivery note before anything is opened. Allocation to territories is then done from the sorted consignment, with the allocation sheet signed, so that the serial-level record of who holds what stays intact. Sample carriers are conditioned and issued as a separate step with their own count sheet; promotional items follow in a separate consignment and never in the same carton. Repairs and replacements are the ongoing case: a damaged carrier or a lost card holder is replaced from the same artwork run, which is the reason a small buffer of ten per cent is agreed at order stage rather than discovered later. Restock at eighteen to thirty months is the natural cycle for bags and at twelve months for printed collateral, and both should be planned against the same artwork master so that a representative never carries two versions of the same brand.

Questions medical representative and field force teams ask

Can the same bag carry both product samples and promotional material?

Not one we would recommend. Samples are regulated goods, and in most jurisdictions they are subject to quantity caps, documented requests, batch traceability, defined handling of expired stock and a record of disposition. A bag that holds both has no compartment structure an auditor can read and produces a stock count that cannot be reconciled. Specify a dedicated carrier for samples with a conditioned insulated compartment, a sealed lid and a printed count sheet inside the lid, and keep promotional stock out of it entirely. This keeps the two categories physically and evidentially separate, which is what the internal policy is usually actually asking for.

Which branded items usually pass a pharmaceutical compliance review?

Functional items rather than decorative ones: a notepad, a pen, a printed reference card, a printed large-print version of patient information, a bag for carrying printed material, and a lanyard for a company event. What tends not to pass is anything that travels home and becomes a personal possession, anything of perceptible value given one-to-one in a clinical setting, and anything with a therapeutic claim printed on the object. Two design habits help more than most: keep the decoration flat in a single colour so the item photographs as a professional tool rather than a consumer brand, and set the per-item value low enough that nobody has to run a threshold analysis to justify it.

What languages should printed field material be produced in?

Armenian first, since that is the working language of clinical contact, with Russian and English alongside it wherever the material reaches hospital administration or a mixed clinical audience. The three-language check should be done by a person who reads all three, and the layout should assume that Armenian sets longer than Russian and expands further at the same point size, which affects panel widths on bags and fit on notebooks. Large-print and accessible versions of patient-facing material are worth producing as a separate line rather than adapting later; in European markets accessible formats are an obligation rather than a courtesy.

Is Corp-Merch affiliated with, endorsed by, or an official supplier to the pharmaceutical companies, congresses, or authorities referenced on this page?

No. Corp-Merch is an independent B2B merchandise supplier and has no relationship with any pharmaceutical company, distributor, congress, association or regulator. It does not supply, handle, store or distribute medicinal products, does not advise on compliance or advertising policy, and does not participate in any tender process. References to national advertising rules, good distribution practice, EU directive requirements, customs headings, EAEU procedures and congress practices are informational only and imply no partnership, sponsorship, endorsement or official-supplier relationship.

This page is written for pharmaceutical commercial operations, field force, marketing, medical affairs and distribution teams operating in Armenia, the wider EAEU and international markets. Corp-Merch is an independent B2B merchandise supplier and produces physical promotional and operational items only. Nothing on this page constitutes legal, regulatory, medical or compliance advice, and nothing on it should be read as an interpretation of advertising rules, good distribution practice requirements, tender rules or sample-handling obligations; confirm the requirements applicable to your products and your company with your own counsel and quality function before ordering. Quantities, lead times and cost ranges describe typical practice for this category and are not a quotation or an offer; every order is specified and priced individually.